Smoking Cessation Program in the Preadmission Clinic: The Use of a Teachable Moment

Not Applicable

Completed

• Conditions: Smoking
• Interventions: Drug: Champix

• Registration Number: NCT01243203
• Lead Sponsor: University Health Network, Toronto

Brief Summary

The Objective of this study is to introduce a practically feasible multifaceted intervention in the preadmission clinic to help reduce smoking in preoperative surgical patients. The investigators aim to study the effectiveness of such a program in promoting positive change in smoking behavior among patients before surgery. The forced abstinence enforced on patients during hospital stay for their surgery can also be used to help smokers remain tobacco free long term. A significant percentage of surgical patients will be receptive to smoking cessation interventions in the preadmission clinic and will refrain from smoking at 24 and 52 weeks after starting the treatment.

Detailed Description

Not available

Study Timeline

• Study Start: 2007-11
• Primary Completion: 2010-11
• Study First Submitted: 2010-11-16
• Study First Submitted QC: 2010-11-17
• Study First Posted: 2010-11-18
• Study Completion: 2011-11
• Status Verified: 2013-11
• Last Update Submitted: 2017-05-04
• Last Update Posted: 2017-05-08

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

• The investigators will recruit patients who are assessed in preadmission clinic and scheduled for elective surgical procedures within the next 8 to 30 days.
• Patients should be 18 yrs of age, have smoked an average 10 cigarettes/day or more during the previous year and had no period of smoking abstinence longer than 3 months in the past year.

Read More

Exclusion Criteria

• current pregnancy, breastfeeding;
• major depression, panic disorder, psychosis, or bipolar disorder within the prior year;
• use of nicotine replacement or bupropion within the previous 3 months;
• cardiovascular disease within the past 6 months;
• a serious or unstable disease within the past 6 months;
• drug or alcohol abuse or dependence within the past year;
• and use of tobacco products other than cigarettes or marijuana use within the previous month;
• participating in any other studies
• Patients who cannot understand English or have any form of cognitive impairment will be excluded.

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Placebo	Champix	patient will receive placebo pills

Primary Outcome Measures

Name	Time	Method
A significant percentage of surgical patients will be receptive to smoking cessation interventions in the preadmission clinic and will refrain from smoking at 24 and 52 weeks after starting the treatment.	2 years

Secondary Outcome Measures

Name	Time	Method
Patients who receive interventions but do not quit smoking will have reduced number of cigarettes consumed /day or improved "stage of change" (determined by Prochaska and DiClemente's Model) at 24 and 52 weeks after starting the treatment.	2 years

Trial Locations

Locations (1)

University Health Network, Department of Anesthesai; 🇨🇦 Toronto, Ontario, Canada